⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions
globenewswire.com
SNY
REGN
Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica
globenewswire.com
AMGN
LULU
CAT
REGN
TMO
BIIB
GILD
BMY
MRK
SNY
Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)
prnewswire.com
AMGN
AZN
SNY
REGN
House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English
prnewswire.com
ALKS
STG
GSK
SNY
TEVA
AZN
INCY
REGN
PFE
BMY
LLY
AMGN
ABBV
GILD
BIIB
CSL
VRTX
BHC
NVS
MRK
LEO
ALLT
CNTB
INM
Central Nervous System Therapeutic Market Report 2025-2033: Key Drivers, Regional Nuances, Competitive Dynamics | Astute Analytica
globenewswire.com
BMY
MNMD
CYBN
ATAI
NUMI
REGN
NVS
85 years of bold discovery: Texas Biomed marks milestone anniversary
prnewswire.com
PFE
NVAX
REGN
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
NVS
BIIB
VTRS
UCB
BMY
ABBV
REGN
SNY
LLY
JNJ
HOPE
GCBC
AMGN
TAK
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
businesswire.com
PFE
AZN
UMBF
CLLS
REGN
Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
globenewswire.com
JNJ
BIIB
NVS
VTRS
RPRX
ABBV
AZN
MRK
RIGL
GSK
REGN
GILD
AMGN
LLY
BMY
XBI
IBB
Adimab Records Another Year of Double-Digit Clinical Program Growth
prnewswire.com
GSK
BIIB
NVS
BMY
REGN
VRTX
LLY
MRK
ALNY
IVVD
ALE
SCHR